Posted inStock Dow futures slip 214 points amid Fed jitters: 5 things to know before Wall Street opens Dow futures were under pressure on Friday, falling about 214 points, roughly 0.5% as investors… November 14, 2025 Posted inStock How Caterpillar is emerging as an AI giant: Wells Fargo Caterpillar shares may still have room to climb, according to Wells Fargo, which initiated coverage… November 14, 2025 Posted inStock Goldman Sachs says this AI name is a better pick than Palantir stock for 2026 Palantir Technologies Inc (NASDAQ: PLTR) has pulled back in recent days amidst a broader sell-off… November 14, 2025 Posted inStock MSTR stock price analysis as mNAV drops below 1 The MSTR stock price has collapsed this year, moving from the year-to-date high of $456… November 14, 2025 Posted inStock The next wave of AI-driven cost cuts: Vista and Meta send clear signals this week The private equity and big tech playbooks are converging on a singular strategy: replace expensive… November 14, 2025 Posted inStock Merck to buy Cidara Therapeutics for $9.2 billion as Keytruda patent cliff approaches Merck & Co. has agreed to acquire biotechnology firm Cidara Therapeutics in a $9.2 billion… November 14, 2025
Posted inStock How Caterpillar is emerging as an AI giant: Wells Fargo Caterpillar shares may still have room to climb, according to Wells Fargo, which initiated coverage… November 14, 2025 Posted inStock Goldman Sachs says this AI name is a better pick than Palantir stock for 2026 Palantir Technologies Inc (NASDAQ: PLTR) has pulled back in recent days amidst a broader sell-off… November 14, 2025 Posted inStock MSTR stock price analysis as mNAV drops below 1 The MSTR stock price has collapsed this year, moving from the year-to-date high of $456… November 14, 2025 Posted inStock The next wave of AI-driven cost cuts: Vista and Meta send clear signals this week The private equity and big tech playbooks are converging on a singular strategy: replace expensive… November 14, 2025 Posted inStock Merck to buy Cidara Therapeutics for $9.2 billion as Keytruda patent cliff approaches Merck & Co. has agreed to acquire biotechnology firm Cidara Therapeutics in a $9.2 billion… November 14, 2025
Posted inStock Goldman Sachs says this AI name is a better pick than Palantir stock for 2026 Palantir Technologies Inc (NASDAQ: PLTR) has pulled back in recent days amidst a broader sell-off… November 14, 2025 Posted inStock MSTR stock price analysis as mNAV drops below 1 The MSTR stock price has collapsed this year, moving from the year-to-date high of $456… November 14, 2025 Posted inStock The next wave of AI-driven cost cuts: Vista and Meta send clear signals this week The private equity and big tech playbooks are converging on a singular strategy: replace expensive… November 14, 2025 Posted inStock Merck to buy Cidara Therapeutics for $9.2 billion as Keytruda patent cliff approaches Merck & Co. has agreed to acquire biotechnology firm Cidara Therapeutics in a $9.2 billion… November 14, 2025
Posted inStock MSTR stock price analysis as mNAV drops below 1 The MSTR stock price has collapsed this year, moving from the year-to-date high of $456… November 14, 2025 Posted inStock The next wave of AI-driven cost cuts: Vista and Meta send clear signals this week The private equity and big tech playbooks are converging on a singular strategy: replace expensive… November 14, 2025 Posted inStock Merck to buy Cidara Therapeutics for $9.2 billion as Keytruda patent cliff approaches Merck & Co. has agreed to acquire biotechnology firm Cidara Therapeutics in a $9.2 billion… November 14, 2025
Posted inStock The next wave of AI-driven cost cuts: Vista and Meta send clear signals this week The private equity and big tech playbooks are converging on a singular strategy: replace expensive… November 14, 2025 Posted inStock Merck to buy Cidara Therapeutics for $9.2 billion as Keytruda patent cliff approaches Merck & Co. has agreed to acquire biotechnology firm Cidara Therapeutics in a $9.2 billion… November 14, 2025
Posted inStock Merck to buy Cidara Therapeutics for $9.2 billion as Keytruda patent cliff approaches Merck & Co. has agreed to acquire biotechnology firm Cidara Therapeutics in a $9.2 billion… November 14, 2025
Posted inStock How Leonard Lauder turned Estée Lauder from a family firm into a global powerhouse Leonard A Lauder, the longtime steward of Estée Lauder Companies and the son of its… June 16, 2025
Posted inStock JPMorgan says buy Newell stock to hedge against tariffs Newell Brands Inc (NASDAQ: NWL) is currently down more than 50% versus its year-to-date, but… June 16, 2025
Posted inStock Up 909% in 3 years: can Rolls-Royce sustain its rally? Rolls-Royce Holdings plc (LSE: RR.) has become one of the most closely watched stocks on… June 16, 2025
Posted inStock Top 4 catalysts for the S&P 500 VOO ETF stock this week The Vanguard S&P 500 ETF (VOO) crashed by over 1.10% on Friday as fresh geopolitical… June 16, 2025
Posted inStock WhatsApp’s ad-free days are over as Meta begins monetization push Meta has officially announced plans to introduce advertisements to WhatsApp, nearly 11 years after acquiring… June 16, 2025
Posted inStock Meta’s AI push drives stock higher: is there further upside or is the stock fully priced? Meta Platforms Inc. has once again captured the attention of Wall Street with its aggressive… June 16, 2025
Posted inStock US stocks rebound on Mon: Dow Jones up 0.6%, Nasdaq jumps 1% US stocks rose Monday, rebounding from last week’s sharp sell-off as investors grew hopeful that… June 16, 2025
Posted inStock Why is Anne Wojcicki regaining control of 23andMe and what it means for genomics firm Anne Wojcicki, cofounder and former chief executive of 23andMe, is taking back control of the… June 16, 2025
Posted inStock Trump Mobile: Trump organization unveils $499 smartphone, unlimited plans US President Donald Trump’s family-owned Trump Organization on Monday announced the launch of Trump Mobile.… June 16, 2025
Posted inStock Is Amazon and Walmart’s stablecoin plan a threat for payment companies? With retail giants Amazon and Walmart reportedly planning to issue their stablecoins, shares of payment… June 16, 2025